Evidence map›Paper›PMID 32606182›Full record

ArticleIn vivo (Athens, Greece)

Synchronous Bilateral Carcinoma of the Ureters. Report of a Case and a Short Discussion of the Literature.

Dimitrios Sidiropoulos, Filippos Kapogiannis, Panagiota Kripouri, Dimitrios Filippou, Konstantinos Vlassis

Open access · diamondAbstract readCase Reports
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dimitrios Sidiropoulos *Department of Urology, General Hospital of Katerini, Katerini, Greece sidiropd2@hotmail.com.
Filippos Kapogiannis *Department of Urology, Hippokrateion General Hospital of Athens, Athens, Greece.
Panagiota KripouriDepartment of Anatomy and Surgical Anatomy, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Dimitrios FilippouDepartment of Anatomy and Surgical Anatomy, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Konstantinos VlassisDepartment of Anatomy and Surgical Anatomy, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimThe strategy for treatment of bilateral simultaneous renal pelvic and/or ureteral tumors has not been established and is dependent on individual decision. CASE REPORT: We herein report the case of an elderly man who was examined for fatigue at the emergency department and subsequently diagnosed with bilateral ureteral cancer. The most common histologic type of ureteral cancer is urothelial (transitional epithelium) cancer and though it is rare, it can be synchronously present in the contralateral ureter. Computed tomography-urography (CTU) has very good results regarding diagnosis and surgical treatment and -though not preferred in our case-, it has shown promising results.

conclusionWe believe that conservative treatment is a viable therapeutic option for simultaneous bilateral renal pelvic and/or ureteral tumors in selected patients. Yet, this treatment has seldom been performed, although standard therapy with bilateral nephroureterectomy inevitably requires the support of hemodialysis or renal transplantation.

Indexed as

Carcinoma, Transitional CellKidney TransplantationUreterUreteral NeoplasmsAgedHumansKidney PelvisMaleBilateral cancercomorbiditiessynchronousureter

Identifiers

PMID32606182
PMCPMC7439911
OpenAlexW3039646558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.